2022

We are happy to announce the expansion of our bioinformatics team with the addition of Rodrigo Meneses. Rodrigo has a Masters degree in Bioinformatics from Ghent University and a strong biological background due to his degree from the University of Aveiro. His experience within a medical setting is a great addition to the team and will help Cyclomics to propel… Read More »Appointment of Rodrigo Meneses as Bioinformatics Scientist at Cyclomics

We are happy to announce our newest team member to join Cyclomics. With a background in Biology, Rita Ferreira holds a PhD degree in Medical Microbiology (2022) from the University of Groningen. Rita’s expertise in cell and molecular biology will contribute to the design and implementation of novel molecular assays and the overall development of the laboratory of Cyclomics. “I… Read More »Appointment of Rita Ferreira as Molecular Biology Scientist at Cyclomics.

Our technology, CyclomicsSeq, has been used in a recent Clinical Proof-of-Concept(Cpoc) project funded by the Oncode Institute. In this project several patients with advanced head and neck cancer were monitored over several months to obtain information about responders and non-responders for the given treatment. The project was performed in collaboration with the Netherlands Cancer Institute and the University Medical Center… Read More »Cyclomics finalizes Oncode clinical proof-of-concept project

Cyclomics’ CSO Wigard Kloosterman presented the CyclomicsSeq technology at the online Cancer Research Symposium organised by Oxford Nanopore Technologies. The recording of the presentation is now available online. The presentation covers details of the CyclomicsSeq technology, which enables consensus sequencing of DNA fragments using the Oxford Nanopore sequencing instruments. Cyclomics aims at delivering flexible, accurate and cost-efficient solutions for detection… Read More »Cyclomics presents technology at Oxford Nanopore Cancer Research Symposium